FORTE, DORIAN
 Distribuzione geografica
Continente #
AS - Asia 2.984
NA - Nord America 2.729
EU - Europa 1.830
SA - Sud America 181
Continente sconosciuto - Info sul continente non disponibili 167
AF - Africa 164
OC - Oceania 6
Totale 8.061
Nazione #
US - Stati Uniti d'America 2.640
VN - Vietnam 816
SG - Singapore 734
CN - Cina 702
IT - Italia 599
GB - Regno Unito 275
DE - Germania 202
SE - Svezia 193
HK - Hong Kong 191
BR - Brasile 131
IN - India 126
KR - Corea 111
FR - Francia 103
NL - Olanda 79
BD - Bangladesh 78
FI - Finlandia 76
IE - Irlanda 65
CA - Canada 55
RU - Federazione Russa 54
TG - Togo 47
CI - Costa d'Avorio 39
JP - Giappone 39
BG - Bulgaria 30
TR - Turchia 29
ZA - Sudafrica 29
BE - Belgio 25
JO - Giordania 21
ID - Indonesia 20
TH - Thailandia 19
TW - Taiwan 19
EE - Estonia 18
UA - Ucraina 18
AT - Austria 17
PH - Filippine 17
CH - Svizzera 16
MX - Messico 15
IQ - Iraq 14
PL - Polonia 14
ES - Italia 13
AR - Argentina 12
EC - Ecuador 12
IR - Iran 12
SC - Seychelles 11
NG - Nigeria 10
CL - Cile 9
LT - Lituania 8
PK - Pakistan 8
MY - Malesia 6
VE - Venezuela 6
EG - Egitto 5
JM - Giamaica 5
MA - Marocco 5
TN - Tunisia 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CR - Costa Rica 4
PT - Portogallo 4
GT - Guatemala 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
UZ - Uzbekistan 3
CZ - Repubblica Ceca 2
ET - Etiopia 2
GA - Gabon 2
GH - Ghana 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
LB - Libano 2
LV - Lettonia 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PE - Perù 2
PS - Palestinian Territory 2
PY - Paraguay 2
RO - Romania 2
SA - Arabia Saudita 2
AG - Antigua e Barbuda 1
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
CO - Colombia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
HR - Croazia 1
KG - Kirghizistan 1
KY - Cayman, isole 1
KZ - Kazakistan 1
MD - Moldavia 1
Totale 7.891
Città #
Singapore 524
Ashburn 349
Chandler 245
San Jose 236
Southend 212
Ho Chi Minh City 192
Hong Kong 173
Hanoi 156
Hefei 156
Bologna 127
Fairfield 125
Dong Ket 105
Seoul 100
Beijing 97
Santa Clara 95
Ann Arbor 81
Milan 70
Wilmington 69
Council Bluffs 65
Dublin 65
Princeton 60
Seattle 57
Houston 55
Helsinki 52
New York 50
Boardman 48
Dallas 47
Lomé 47
Woodbridge 47
Cambridge 46
Los Angeles 40
Abidjan 39
Lauterbourg 35
Cornaredo 32
Tokyo 28
Sofia 27
Haiphong 26
Rome 26
Da Nang 25
Turin 25
Buffalo 24
Hyderabad 24
Munich 24
Redmond 24
Bremen 23
Brussels 23
Berlin 22
Westminster 21
Amman 20
Clifton 20
Nanjing 20
São Paulo 19
Burdur 18
Bengaluru 17
Frankfurt am Main 17
Jinan 17
Redondo Beach 17
Toronto 16
Lappeenranta 15
Manaus 15
North Bergen 15
Padova 15
Shanghai 15
Shenyang 15
London 14
Jakarta 13
Johannesburg 13
Nuremberg 13
Piscataway 13
San Diego 13
Hangzhou 12
Montreal 12
Biên Hòa 11
Guangzhou 11
Abeokuta 10
Changsha 10
Florence 10
Medford 10
Redwood City 10
San Francisco 10
Bern 9
Norwalk 9
Rimini 9
Saint Petersburg 9
Secaucus 9
Stockholm 9
Taiyuan 9
Tianjin 9
Warsaw 9
Amsterdam 8
Boston 8
Falkenstein 8
Fremont 8
Orem 8
Quận Bình Thạnh 8
Shenzhen 8
Turku 8
Chennai 7
Hải Dương 7
Nanchang 7
Totale 4.861
Nome #
Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn's disease patients in a mouse model of colitis 312
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia 295
Circulating calreticulin is increased in myelofibrosis: Correlation with interleukin-6 plasma levels, bone marrow fibrosis, and splenomegaly 265
CIRCULATING CD34+ STEM/PROGENITOR CELLS FROM TRIPLE NEGATIVE PATIENTS WITH MYELOFIBROSIS SHOW DIFFERENT NUMBER, GENE EXPRESSION PROFILE AND IN VITRO RESPONSE TO INFLAMMATORY STIMULI AS COMPARED WITH THE JAK2(V617F) MUTATED COUNTERPARTS 233
Disease-specific derangement of circulating endocannabinoids and n-acylethanolamines in myeloproliferative neoplasms 231
CIRCULATING PLATELET AND MEGAKARYOCYTE-DERIVED MICROPARTICLES OF JAK2V617F MUTATED PATIENTS WITH MYELOFIBROSIS ARE DISREGULATED: A NOVEL LIQUID BIOPSY TOOL OF RESPONSE TO RUXOLITINIB? 229
Distinct profile of CD34+ cells and plasma-derived extracellular vesicles from triple-negative patients with Myelofibrosis reveals potential markers of aggressive disease 218
STUDIO DELLA FUNZIONE E DEL PROFILO DEI MICRORNA IN MICROPARTICELLE CIRCOLANTI ISOLATE DA PAZIENTI ‘TRIPLI NEGATIVI’ E JAK2V617F MUTATI CON MIELOFIBROSI 211
Mobilized Peripheral Blood versus Cord Blood: Insight into the distinct role of proinflammatory cytokines on survival, clonogenic ability, and migration of CD34+ cells 208
Circulating Platelet Vs Megakaryocyte-Derived Microparticles Identify Myelofibrosis Patients with JAK2V617F Mutation, High Disease Burden and Ruxolitinib Response 205
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure 204
Platelet lysate enhances the therapeutic activity of Adipose Derived Mesenchymal stromal cells isolated from Crohn disease patients in a novel Mouse model of Colitis 202
The more, the better: "Do the right thing" for natural killer immunotherapy in acute myeloid leukemia 200
Parallel single-cell metabolic analysis and extracellular vesicle profiling reveal vulnerabilities with prognostic significance in acute myeloid leukemia 199
Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis 199
IDENTIFICATION OF POLYCYTHEMIA VERA-SPECIFIC BIOMARKERS OF OUTCOME BY NOVEL MULTIDIMENSIONAL ANALYSIS APPROACHES 197
Crucial factors of the inflammatory microenvironment (IL-1β/ TNF-α/TIMP-1) promote the maintenance of the malignant hemopoietic clone of myelofibrosis: an in vitro study 194
TOWARD THE IDENTIFICATION OF A MICRORNA-BASED SIGNATURE OF CIRCULATING MICROPARTICLES FROM TRIPLE NEGATIVE AND JAK2(V617F) MUTATED PATIENTS WITH MYELOFIBROSIS 193
The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study 192
The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling 189
Bone Marrow Mesenchymal Stem Cells Support Acute Myeloid Leukemia Bioenergetics and Enhance Antioxidant Defense and Escape from Chemotherapy 188
Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells 186
Corrigendum: Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells (Front. Oncol, (2020), 10, (1225), 10.3389/fonc.2020.01225) 186
Circulating extracellular particles from severe COVID-19 patients show altered profiling and innate lymphoid cell-modulating ability 184
Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis 183
The tissue inhibitor of metalloproteinases 1 increases the clonogenic efficiency of human hematopoietic progenitor cells through CD63/PI3K/Akt signaling 173
The “vesicular intelligence” strategy of blood cancers 173
Crucial Factors of the Inflammatory Microenvironment (IL-1 beta/TNF-alpha/TIMP-1) Promote Maintenance of the Malignant Hemopoietic Clone of Myelofibrosis By Stimulating the in Vitro Survival/Proliferation/Migration of Circulating CD34+ stem/Progenitor Cells 171
Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cells 170
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches 167
Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic Targets 167
Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis 159
INFLAMMATORY PATHWAYS IN THE BONE MARROW: ROLE OF TIMP-1 IN HEMATOPOIETIC STEM/PROGENITOR CELLS AND LEUKEMIA 153
The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosis 149
Emerging bone marrow microenvironment‐driven mechanisms of drug resistance in acute myeloid leukemia: Tangle or chance? 140
Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data 139
The Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) Regulates the Function and Migration of Leukemic Blasts through CD63/PI3K/AKT/P21 Axis 135
Bone marrow mesenchymal stromal cells support translation in refractory acute myeloid leukemia 125
KAT2A complexes ATAC and SAGA play unique roles in cell maintenance and identity in hematopoiesis and leukemia 123
Updates on the hematologic tumor microenvironment and its therapeutic targeting 117
Validation Study of Analytical Methods for Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in Acute Myeloid Leukemia 111
Single-Cell Metabolic Profiling Integrated with Extracellular Vesicle Analysis Reveals Novel Metabolic Vulnerabilities and Prognostic Biomarkers in Acute Myeloid Leukemia 98
Clinical Implications of Plasma-Derived Extracellular Vesicles in Myeloproliferative Neoplasms: Unveiling Inflammatory Potential and Biomarkers for Cancer Treatment 79
Extracellular Vesicle-Based Liquid Biopsy Shows Clinical Relevance and Reveals Links with Single-Cell Metabolic Signature in Acute Myeloid Leukemia 71
Noncanonical NF-κB signaling in dendritic cells is required for ATP-driven indoleamine 2,3-dioxygenase 1 induction through P2Y11 receptor 54
PICK A WORD: HOW EXTRACELLULAR VESICLES DICTATE THE NORMAL AND LEUKEMIC HEMATOPOIETIC LANDSCAPE 52
Leukemic Stem Cells Co-Opt Normal Bone Marrow Niches As a Source of Energy and Antioxidant Defence 30
null 2
Totale 8.061
Categoria #
all - tutte 21.675
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.675


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022666 0 28 46 60 60 27 14 40 28 73 156 134
2022/2023897 115 139 52 120 51 79 15 43 156 21 56 50
2023/2024342 22 42 14 49 22 55 19 22 17 26 38 16
2024/20251.265 83 106 112 87 124 69 88 69 76 102 96 253
2025/20263.423 332 375 245 216 289 156 313 180 732 272 165 148
2026/2027265 142 123 0 0 0 0 0 0 0 0 0 0
Totale 8.061